Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferroquine + Artesunate in Uncomplicated Malaria
NCT00563914Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Nov 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of ferroquine in Plasmodium falciparum malaria (2 arms), sponsored by Sanofi. Primary endpoint: Hepatic safety parameters (ALT, AST, Alkaline Phosphatase, Total Bilirubin) at Day 28. Started Oct 2007; status: completed.
02
Drugs
ferroquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00563914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563914.